BRPI0606168A2 - separação de isÈmeros de fulvestrant - Google Patents
separação de isÈmeros de fulvestrantInfo
- Publication number
- BRPI0606168A2 BRPI0606168A2 BRPI0606168-0A BRPI0606168A BRPI0606168A2 BR PI0606168 A2 BRPI0606168 A2 BR PI0606168A2 BR PI0606168 A BRPI0606168 A BR PI0606168A BR PI0606168 A2 BRPI0606168 A2 BR PI0606168A2
- Authority
- BR
- Brazil
- Prior art keywords
- fulvestrant
- sulfoxide
- column
- hplc
- isomer separation
- Prior art date
Links
- VWUXBMIQPBEWFH-WCCTWKNTSA-N Fulvestrant Chemical class OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 title abstract 4
- 238000000926 separation method Methods 0.000 title abstract 2
- 229960002258 fulvestrant Drugs 0.000 abstract 6
- -1 fulvestrant sulfoxide Chemical class 0.000 abstract 4
- 238000004128 high performance liquid chromatography Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000003480 eluent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/16—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the fluid carrier
- B01D15/166—Fluid composition conditioning, e.g. gradient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3833—Chiral chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/262—Synthetic macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. obtained by polycondensation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/285—Porous sorbents based on polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
SEPARAçãO DE ISÈMEROS DE FULVESTRANT. A invenção abrange métodos para separar os isómeros de fulvestrant, consistindo em colocar uma amostra de fulvestrant em uma HPLC usando uma coluna de fase reversa ou coluna quiral; eluir a amostra com um eluente tendo uma primeira fase móvel e uma segunda fase móvel, e coletar frações purificadas de fulvestrant sulfóxido A ou de fulvestrant sulfóxido B da coluna. O método fornece fulvestrant sulfóxido A ou fulvestrant sulfóxido B com 99,5% de pureza conforme determinação por HPLC.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72405905P | 2005-10-05 | 2005-10-05 | |
| PCT/US2006/039389 WO2007044662A2 (en) | 2005-10-05 | 2006-10-05 | Separation of fulvestrant isomers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0606168A2 true BRPI0606168A2 (pt) | 2009-06-02 |
Family
ID=37898376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0606168-0A BRPI0606168A2 (pt) | 2005-10-05 | 2006-10-05 | separação de isÈmeros de fulvestrant |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070144968A1 (pt) |
| EP (1) | EP1819344A2 (pt) |
| JP (1) | JP2008521941A (pt) |
| KR (1) | KR20070088695A (pt) |
| CN (1) | CN101272792A (pt) |
| BR (1) | BRPI0606168A2 (pt) |
| CA (1) | CA2619476A1 (pt) |
| MX (1) | MX2007006653A (pt) |
| TW (1) | TW200804408A (pt) |
| WO (1) | WO2007044662A2 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7628920B2 (en) * | 2004-04-07 | 2009-12-08 | Waters Technologies Corporation | Compositions and methods for separating enantiomers |
| CN103221052A (zh) * | 2010-09-16 | 2013-07-24 | 施摩达生物技术有限公司 | 氟维司群组合物及使用方法 |
| CN103965280B (zh) * | 2014-05-21 | 2016-04-20 | 天津孚音生物科技发展有限公司 | 一种氟维司群中间体的制备方法 |
| US10705060B2 (en) * | 2015-02-27 | 2020-07-07 | Waters Technologies Corporation | Spatial temperature gradients in liquid chromatography |
| CN106146599A (zh) * | 2015-04-07 | 2016-11-23 | 江苏希迪制药有限公司 | 一种回收因亚砜构型比例不合格的氟维司群或其衍生物的方法 |
| CN108610392B (zh) * | 2016-12-12 | 2022-03-29 | 江苏豪森药业集团有限公司 | 氟维司群正相色谱纯化方法 |
| CN111548434B (zh) * | 2020-05-12 | 2022-03-22 | 杭州泽邦科技有限公司 | 一种伽马环糊精的分离纯化方法 |
| CN114527205A (zh) * | 2022-01-21 | 2022-05-24 | 石家庄四药有限公司 | 2-叔丁氧羰基氨基-n-苄基-3-甲氧基丙酰胺异构体的检测方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8327256D0 (en) * | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
| AU707942B2 (en) * | 1995-06-14 | 1999-07-22 | Schering Aktiengesellschaft | New vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| EP1071441A1 (en) * | 1998-04-17 | 2001-01-31 | Her Majesty The Queen in Right of Canada, as represented by The Minister of Agriculture and Agri-Food Canada | Process for recovery and purification of saponins and sapogenins from quinoa (chenopodium quinoa) |
| WO2001042235A1 (en) * | 1999-12-13 | 2001-06-14 | Chugai Seiyaku Kabushiki Kaisha | 3-ethyl-, 3-propyl- or 3-butyl-chroman and -thiochroman derivatives |
| WO2001042234A1 (en) * | 1999-12-13 | 2001-06-14 | Chugai Seiyaku Kabushiki Kaisha | 3-methyl-chroman and -thiochroman derivatives |
| GB0116620D0 (en) * | 2001-07-07 | 2001-08-29 | Astrazeneca Ab | Formulation |
| ITRM20020402A1 (it) * | 2002-07-29 | 2004-01-29 | Sigma Tau Ind Farmaceuti | Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine. |
| DE10318896A1 (de) * | 2003-04-22 | 2004-11-25 | Schering Ag | 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene |
-
2006
- 2006-10-05 MX MX2007006653A patent/MX2007006653A/es unknown
- 2006-10-05 BR BRPI0606168-0A patent/BRPI0606168A2/pt not_active IP Right Cessation
- 2006-10-05 TW TW095137253A patent/TW200804408A/zh unknown
- 2006-10-05 US US11/544,522 patent/US20070144968A1/en not_active Abandoned
- 2006-10-05 CA CA002619476A patent/CA2619476A1/en not_active Abandoned
- 2006-10-05 CN CNA2006800355252A patent/CN101272792A/zh active Pending
- 2006-10-05 WO PCT/US2006/039389 patent/WO2007044662A2/en not_active Ceased
- 2006-10-05 EP EP06825645A patent/EP1819344A2/en not_active Withdrawn
- 2006-10-05 JP JP2007544658A patent/JP2008521941A/ja active Pending
- 2006-10-05 KR KR1020077013307A patent/KR20070088695A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008521941A (ja) | 2008-06-26 |
| KR20070088695A (ko) | 2007-08-29 |
| WO2007044662A2 (en) | 2007-04-19 |
| TW200804408A (en) | 2008-01-16 |
| EP1819344A2 (en) | 2007-08-22 |
| CN101272792A (zh) | 2008-09-24 |
| MX2007006653A (es) | 2009-02-17 |
| CA2619476A1 (en) | 2007-04-19 |
| US20070144968A1 (en) | 2007-06-28 |
| WO2007044662A3 (en) | 2007-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0517973B8 (pt) | métodos para purificar o fsh recombinante | |
| WO2006107992A3 (en) | Methods for detecting vitamin d metabolites by mass spectrometry | |
| Pauk et al. | Fast separation of selected cathinones and phenylethylamines by supercritical fluid chromatography | |
| CL2007003264A1 (es) | Compuestos derivados de 1,4-benzotiepina 1,1-dioxido sustituidos con radicales bencilo; producto farmaceutico; y uso para el tratamiento de trastornos del metabolismo de lipidos, hiperlipidemia, resistencia a la insulina, diabetes y trastornos del sn | |
| WO2006078859A3 (en) | Methods for separating compounds | |
| BRPI0812609A2 (pt) | método para separar pelo menos um componente de uma composição que compreenda pelo menos dois derivados de óleos de sementes | |
| WO2005107491A3 (en) | Multi-lectin affinity chromatography and uses thereof | |
| EA200900283A1 (ru) | Комбинированная композитно-стальная колонка несущего винта винтокрылого летательного аппарата | |
| BRPI0721238B8 (pt) | método de purificação da apolipoproteina a-1 | |
| CL2007002427A1 (es) | Compuestos derivados heterociclicos, inhibidores de metaloproteinasa de matriz; proceso de preparacion; composicion farmaceutica, util para el tratamiento o profilaxis de enfermedades inflamatorias o desordenes autoinmunes. | |
| BR112013019508A2 (pt) | purificação de insulina | |
| AR117418A1 (es) | Métodos para la purificación de polipéptidos usando polisorbatos | |
| BRPI0417992B8 (pt) | métodos para purificar fsh humano recombinante ou uma variante de fsh | |
| BR112019007096A2 (pt) | método para a detecção de apolipoproteína e4 | |
| BRPI0622083A2 (pt) | Método e aparelho destinados à fabricação de substratos purificados ou substratos puros que são adicionalmente processados. | |
| BR112016023680A2 (pt) | ?processo de purificação de gonadotropina? | |
| WO2007044662A3 (en) | Separation of fulvestrant isomers | |
| SE0401665D0 (sv) | Purification of immunoglobulins | |
| TW200739068A (en) | Composite chromatography column | |
| DK1891088T3 (da) | Fremgangsmåde til rensning af et IL-18-bindende protein | |
| DK1879580T3 (da) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet | |
| DK1879581T3 (da) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater som lægemidler til behandling af infertilitet | |
| EP4222490A4 (en) | CHROMATOGRAPHY COLUMN | |
| FR2879599B1 (fr) | Utilisation de la chromatographie de partage centrifuge pour la purification de la galanthamine | |
| EP1712905A4 (en) | METHOD FOR SEPARATING OPTICAL ISOMERS USING SUPERCRITICAL LIQUID CHROMATOGRAPHY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 3A, 4A E 5A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |